Story perspectives

AI Revolutionizes Pharma Trials: 35% Productivity Gains Ahead

1/26/2026

Summary

Story summary

AI is accelerating pharma workflows, with executives citing time savings in trials at the JP Morgan Healthcare Conference.
Novartis reduced trial site selection from weeks to two hours, illustrating AI's impact.
AI is aiding patient outreach and document preparation, with McKinsey estimating productivity gains of 35% to 45% over five years.
Analysts caution it may take 1–3 years to gauge AI's impact on drug development efficiency as integration scales.

1 of 1

Story summary

AI is accelerating pharma workflows, with executives citing time savings in trials at the JP Morgan Healthcare Conference.
Novartis reduced trial site selection from weeks to two hours, illustrating AI's impact.
AI is aiding patient outreach and document preparation, with McKinsey estimating productivity gains of 35% to 45% over five years.
Analysts caution it may take 1–3 years to gauge AI's impact on drug development efficiency as integration scales.